JUN and neoplasm: Even though for the most of the 1990s AP-1, especially in its CFOS/CJUN setup, was considered an oncogenic transcription factor in vitro and in vivo [168,169], selected variants of AP-1, dependent on the subunit composition, are not oncogenic or may possess tumor suppressive activities [170].